Results 191 to 200 of about 17,368 (238)

MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial. [PDF]

open access: yesNat Commun
Pearson AT   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy